@extends('layouts.front')

@section('meta')
  <title>Market Access & Product Commercialisation</title>
  <meta name="description" content="">
@endsection

@section('header-content')
  <img class="hidden sm:inline-block w-full" src="{{ asset('/image/hero-market-access.jpg') }}" alt="Smartway Pharmaceuticals - Market Access & Product Commercialisation" title="Smartway Pharmaceuticals - Market Access & Product Commercialisation">
  <img class="inline-block sm:hidden w-full" src="{{ asset('/image/hero-market-access-mobile.png') }}" alt="Smartway Pharmaceuticals - Market Access & Product Commercialisation" title="Smartway Pharmaceuticals - Market Access & Product Commercialisation">
  <div class="gray-radial-gradient opacity-60 absolute top-0 bottom-0 right-0 left-0"></div>
  <div class="container 3xl:max-w-3xl absolute heading text-white lg:px-36 px-4">
    <h1 class="quarto-font 4xl:text-120px xl:text-85px md:text-6xl sm:text-4xl text-42px leading-none mb-3">
      Market Access & Product Commercialisation
    </h1>
  </div>
@endsection

@section('content')
  <section class="container 3xl:max-w-3xl px-4 lg:mt-20 mt-10">
    <h2 class="quarto-font 4xl:text-93px xl:text-62px lg:text-44px text-34px 4xl:leading-102px xl:leading-70px lg:leading-48px leading-40px sm:mb-12 mb-6 4xl:-mr-4 sm:pr-0 pr-2">
      Smartway Pharmaceuticals partners with pharmaceutical manufacturers, product owners and dossier/rights holders to support market access and long‑term commercialisation of licensed medicines.
    </h2>

    <p class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px lg:mb-10 mb-6">
      Through structured in‑licensing and commercialisation arrangements, Smartway supports regulatory approval, including marketing authorisation, market entry and ongoing supply across the UK and selected international markets.
    </p>
    <p class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px">
      Our approach is designed for products that require more than distribution alone - combining regulatory capability, commercial infrastructure and operational execution to deliver sustainable access.
    </p>
    <div class="lg:mt-12 mt-12">
        <h2 class="4xl:text-32px xl:text-2xl text-22px 4xl:leading-37px leading-28px font-bold lg:mt-10 mt-0 mb-6">Who we work with</h2>
        <p class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px">
          We work with pharmaceutical manufacturers, product owners and developers who are seeking:
        </p>
        <ul class="4xl:text-28px text-lg font-semibold -tracking-0.5px mt-6 mb-6">
          <li class="flex items-center">
            <div class="bg-persian-green text-white w-4 h-4 rounded-full flex items-center justify-center mr-3"></div>
            Entry into the UK or other regulated markets
          </li>
          <li class="flex items-center lg:my-5 my-8">
            <div class="bg-persian-green text-white w-4 h-4 rounded-full flex items-center justify-center mr-3"></div>
            A partner to support regulatory approval and commercial launch
          </li>
          <li class="flex items-center lg:my-5 my-8">
            <div class="bg-persian-green text-white w-4 h-4 rounded-full flex items-center justify-center mr-3"></div>
            Long‑term licensed supply and lifecycle management
          </li>
          <li class="flex items-center lg:my-5 my-8">
            <div class="bg-persian-green text-white w-4 h-4 rounded-full flex items-center justify-center mr-3"></div>
            An alternative to building and maintaining in-country commercial infrastructure, including established access to community pharmacy, hospital and specialist healthcare networks
          </li>
          <li class="flex items-center lg:my-5 my-8">
            <div class="bg-persian-green text-white w-4 h-4 rounded-full flex items-center justify-center mr-3"></div>
            Expansion, structured relaunch or lifecycle optimisation within the UK market
          </li>
          <li class="flex items-center">
            <div class="bg-persian-green text-white w-4 h-4 rounded-full flex items-center justify-center mr-3"></div>
            Portfolio / product divestment, structured asset transfer or selective product carve-out within the UK market
          </li>
        </ul>
        <p class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px ">
            We partner with established pharmaceutical companies seeking disciplined regional expansion, as well as product owners with late-stage or under-commercialised assets that require structured regulatory strategy and integrated commercial delivery.
        </p>
    </div>
    <div class="grid grid-cols-1">
      <h2 class="4xl:text-32px xl:text-2xl text-22px 4xl:leading-37px leading-28px font-bold mt-10">What we offer</h2>
      <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5">
        <p>Smartway provides an integrated approach to market access and commercialisation, tailored to the needs of each product and partner.</span></p>
      </div>
    </div>
    <hr class="h-0.5 bg-black lg:my-20 my-10">
  </section>

  <section class="container 3xl:max-w-3xl px-4 lg:mb-20 mb-10">
    <div class="grid xl:grid-cols-2 grid-cols-1 lg:gap-y-20 gap-y-10">
      <div class="xl:pr-32">
        <a href="#" class="quarto-font 4xl:text-62px text-44px leading-none">In‑licensing and product selection</a>
        <img class="xl:hidden sm:w-3/4 my-7" src="{{ asset('image/in‑licensing-and-product-selection.jpg') }}" alt="Smartway Pharmaceuticals - Pharmaceutical, Device & Equipment Supply" title="Smartway Pharmaceuticals - Pharmaceutical, Device & Equipment Supply">
        <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5 xl:mb-16 mb-9">
          <p>
            We enter into structured inward licensing arrangements for products aligned with Smartway’s therapeutic focus, regulatory expertise and supply capabilities. Each opportunity is assessed for regulatory feasibility, commercial sustainability and long-term supply resilience. 
            Smartway pursues opportunities aligned with defined therapeutic focus areas and long-term portfolio strategy.
          </p>
        </div>
      </div>
      <div class="xl:flex hidden items-center">
        <img class="my-auto" src="{{ asset('image/in‑licensing-and-product-selection.jpg') }}" alt="Smartway Pharmaceuticals - Pharmaceutical, Device & Equipment Supply" title="Smartway Pharmaceuticals - Pharmaceutical, Device & Equipment Supply">
      </div>
    </div>
    <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-10 mb-10 lg:mb-0 4xl:pr-20">
      <p>
        Smartway has structured and executed inward licensing arrangements within regulated markets, including shared regulatory investment, MHRA-led approval and MAH-based commercialisation, supporting products through approval and long-term commercial supply.
      </p>
    </div>

    <div class="grid xl:grid-cols-2 grid-cols-1 lg:mt-20 mt-10 lg:mb-20 mb-10">
      <div class="xl:flex hidden items-center">
        <img src="{{ asset('image/regulatory-strategy-and-execution.jpg') }}" alt="Smartway Pharmaceuticals - Global Distribution & Storage Network" title="Smartway Pharmaceuticals - Global Distribution & Storage Network">
      </div>
      <div class="xl:pl-24">
        <a href="#" class="quarto-font 4xl:text-62px text-44px leading-none">Regulatory strategy and execution</a>
        <img class="xl:hidden sm:w-3/4 my-7" src="{{ asset('image/regulatory-strategy-and-execution.jpg') }}" alt="Smartway Pharmaceuticals - Global Distribution & Storage Network" title="Smartway Pharmaceuticals - Global Distribution & Storage Network">
        <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5 xl:mb-16 mb-9 xl:pr-5">
          <p class="lg:mb-9 mb-5">
            Smartway supports regulatory strategy and execution, including dossier development, remediation and submission, as well as ongoing regulatory maintenance. We work closely with partners and regulatory authorities to support approval and continued compliance throughout the product lifecycle.
          </p>
        </div>
      </div>
    </div>

    <div class="grid xl:grid-cols-2 grid-cols-1 lg:mt-20 mt-10 lg:mb-20 mb-10">
      <div class="xl:pr-28">
        <a href="#" class="quarto-font 4xl:text-62px text-44px leading-none">Licensed supply and commercial launch</a>
        <img class="xl:hidden sm:w-3/4 my-7" src="{{ asset('image/licensed-supply-and-commercial-launch.jpg') }}" alt="Smartway Pharmaceuticals - Kitting" title="Smartway Pharmaceuticals - Kitting">
        <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5 xl:mb-16 mb-9">
          <p>
            Approved products are supported through licensed manufacture and supply arrangements, underpinned by Smartway’s established national distribution infrastructure serving community pharmacy, 
            hospital systems, specialist prescribers and private healthcare providers across the UK and selected European and international markets. 
          </p>
        </div>
      </div>
      <div class="xl:flex hidden items-center">
        <img class="my-auto" src="{{ asset('image/licensed-supply-and-commercial-launch.jpg') }}" alt="Smartway Pharmaceuticals - Kitting" title="Smartway Pharmaceuticals - Kitting">
      </div>
    </div>

    <div class="grid xl:grid-cols-2 grid-cols-1 lg:gap-y-20 gap-y-10">
      <div class="xl:flex hidden items-center">
        <img class="my-auto" src="{{ asset('image/lifecycle-and-portfolio-management.jpg') }}" alt="Smartway Pharmaceuticals - Project Management" title="Smartway Pharmaceuticals - Project Management">
      </div>
      <div class="xl:pl-24">
        <a href="#" class="quarto-font 4xl:text-62px text-44px leading-none sm:mr-0 -mr-4 block">Lifecycle and portfolio management</a>
        <img class="xl:hidden sm:w-3/4 my-7" src="{{ asset('image/lifecycle-and-portfolio-management.jpg') }}" alt="Smartway Pharmaceuticals - Project Management" title="Smartway Pharmaceuticals - Project Management">
        <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5 xl:mb-16 mb-9 xl:pr-8">
          <p class="4xl:-mr-3">
            Beyond initial launch, Smartway provides ongoing commercial, regulatory and supply chain management to support sustainable access, continuity of supply and long‑term portfolio value.
          </p>
        </div>
      </div>

      <div class="xl:pr-24">
        <a href="#" class="quarto-font 4xl:text-62px text-44px leading-none">From access to approval</a>
        <img class="lg:hidden my-7" src="{{ asset('image/from-access-to-approval.jpg') }}" alt="Smartway Pharmaceuticals - Resource Centre" title="Smartway Pharmaceuticals - Resource Centre">
        <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5 xl:mb-16 mb-9">
          <p class="lg:mb-9 mb-5">
            While Smartway supports early access and unlicensed supply where clinically appropriate, our market access and commercialisation activities are focused on transitioning products into licensed, sustainable supply.
          </p>
          <p>This approach supports continuity of access for patients and healthcare professionals, while providing partners with a clear and proportionate route to long‑term commercialisation.</p>
        </div>
        
      </div>
      <div class="lg:flex hidden items-center">
        <img class="my-auto" src="{{ asset('image/from-access-to-approval.jpg') }}" alt="Smartway Pharmaceuticals - Resource Centre" title="Smartway Pharmaceuticals - Resource Centre">
      </div>
    </div>

    <hr class="h-0.5 bg-black lg:my-20 my-10">

    <div class="grid grid-cols-1">
      <h2 class="4xl:text-32px xl:text-2xl text-22px 4xl:leading-37px leading-28px font-bold">Why partner with Smartway</h2>
      <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5">
        <p>
          Smartway combines regulatory expertise with established commercial and distribution infrastructure, allowing partners to progress from approval to routine supply without fragmentation or unnecessary hand-offs.
        </p>
      </div>
      <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5 post-content">
        <blockquote>
          <p>
            <span>
              <span>
                <em>"We approach licensed products as long-term portfolio assets, not short-term transactions. We invest alongside our partners in regulatory conversion and MAH-led commercialisation to ensure products move into sustained, 
                  compliant routine supply within the healthcare system."</em> - 
                <strong>Josh Cocklin, Chief Executive</strong>
              </span>
            </span>
          </p>
        </blockquote>
      </div>
 
      <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5">
        <p>
          Unlike pure regulatory service providers or standalone distributors, Smartway integrates regulatory execution with established supply pathways, enabling a seamless transition from approval to routine commercial supply. 
        </p>
      </div>
      <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5">
        <p>
          Smartway uniquely combines regulatory execution, inward licensing capability and established national distribution infrastructure serving community pharmacy, hospital systems, specialist prescribers and private healthcare providers, within a single integrated platform.
        </p>
      </div>
      <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5">
        <p>
          For decades, Smartway has supplied medicines across community pharmacy, hospital systems, specialist prescribers and private healthcare settings. This established and embedded operational presence, supported by national distribution capability and export activity, provides partners with direct access to routine, compliant supply pathways within the UK healthcare system and selected international markets.
        </p>
      </div>
      <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5">
        <p>
          This embedded operational presence is supported by established compliance systems, pharmacovigilance oversight and quality governance frameworks aligned with UK regulatory expectations, providing partners with confidence in both regulatory stewardship and commercial execution.
        </p>
      </div>
      <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5">
        <p>
          Our experience across early access programmes, licensed distribution and international supply enables a joined-up approach to market entry in complex and constrained environments, supporting both regulatory confidence and commercial delivery.
        </p>
      </div>
    </div>
  </section>
  <section class="container 3xl:max-w-3xl px-4 lg:mb-20 mb-10">
    <p class="4xl:text-32px xl:text-2xl text-22px 4xl:leading-37px leading-28px font-bold text-center">Typical engagement models</p>
    <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-5 text-center">
        <p>
          Smartway structures partnerships to reflect the regulatory status, maturity and commercial objectives of each product. 
          <span class="block">Typical models include:</span>
        </p>
    </div>
    <div class="xl:grid hidden grid-cols-5 gap-6 lg:mt-16 mt-7 4xl:text-22px text-lg pb-4 xl:px-0 px-6">
      <div class="bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 pb-16 px-2">
        <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
          <img src="{{ asset('image/In‑licensing.png') }}"
            alt="Smartway Pharmaceuticals - In‑licensing and commercialisation partnerships" title="Smartway Pharmaceuticals - In‑licensing and commercialisation partnerships"/>
        </div>
        <p class="font-bold leading-tight mb-3">
          <span class="block">In‑licensing and</span>
          <span class="block">commercialisation partnerships</span>
        </p>
        <p>
          Structured inward licensing arrangements where Smartway supports regulatory approval, commercial launch and long‑term licensed supply within defined territories.
        </p>
      </div>

      <div class="bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 pb-16 px-2">
        <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
          <img src="{{ asset('image/lifecycle-management.png') }}" alt="Smartway Pharmaceuticals - MAH‑led market entry and lifecycle management" title="Smartway Pharmaceuticals - MAH‑led market entry and lifecycle management"/>
        </div>
        <p class="font-bold leading-tight mb-3">
          <span class="block">MAH‑led market entry and</span>
          <span class="block">lifecycle management</span>
        </p>
        <p>
          Support for regulatory approval for marketing authorisations and ongoing maintenance, combined with integrated commercial supply and distribution across hospital and pharmacy settings.
        </p>
      </div>
      
      <div class="bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 px-5 pb-16">
        <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
          <img src="{{ asset('image/End-to-end.svg') }}" alt="Smartway Pharmaceuticals - Transition from early access to licensed supply" title="Smartway Pharmaceuticals - Transition from early access to licensed supply"/>
        </div>
        <p class="font-bold leading-tight mb-10">
          <span class="block">Transition from early</span>
          <span class="block">access to licensed supply</span>
        </p>
        <p>
          Planning and execution of the pathway from unlicensed or early access supply into routine, licensed commercial distribution, supporting continuity of access.
        </p>
      </div>

      <div class="bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 pb-16 px-4">
        <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
          <img src="{{ asset('image/regional-partnerships.png') }}" alt="Smartway Pharmaceuticals - Regional or portfolio expansion partnerships" title="Smartway Pharmaceuticals - Regional or portfolio expansion partnerships"/>
        </div>
        <p class="font-bold leading-tight mb-10">
          <span class="block">Regional or portfolio</span>
          <span class="block">expansion partnerships</span>
        </p>
        <p>
          Selective territory commercialisation for established products, providing regulatory and commercial infrastructure without the need for in‑country build‑out.
        </p>
      </div>

      <div class="bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 pb-16 px-8">
        <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
          <img src="{{ asset('image/strategic-discussion.png') }}" alt="Smartway Pharmaceuticals - Initiate a strategic discussion" title="Smartway Pharmaceuticals - Initiate a strategic discussion"/>
        </div>
        <p class="font-bold leading-tight mb-10">
          Initiate a strategic discussion
        </p>
        <p>
          Market access and product commercialisation is a core strategic function within Smartway. We engage selectively with partners seeking structured, long-term entry into the UK and regulated international markets.
        </p>
      </div>
    </div>

    <div class="xl:hidden lg:mt-16 mt-7 4xl:text-22px text-lg xl:px-0 px-4">
      <div class="why-partner-slider">
        <div class="glide__track" data-glide-el="track">
          <div class="glide__slides">
            <div class="glide__slide bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 pb-16 px-2 mr-6 my-2">
              <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
                <img src="{{ asset('image/In‑licensing.png') }}" 
                  alt="Smartway Pharmaceuticals - In‑licensing and commercialisation partnerships" title="Smartway Pharmaceuticals - In‑licensing and commercialisation partnerships"/>
              </div>
              <p class="font-bold leading-tight mb-3">
                <span class="block">In‑licensing and</span>
                <span class="block">commercialisation partnerships</span>
              </p>
              <p>
                Structured inward licensing arrangements where Smartway supports regulatory approval, commercial launch and long‑term licensed supply within defined territories.
              </p>
            </div>

            <div class="glide__slide bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 pb-16 px-2 mr-6 my-2">
              <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
                <img src="{{ asset('image/lifecycle-management.png') }}" alt="Smartway Pharmaceuticals - MAH‑led market entry and lifecycle management" title="Smartway Pharmaceuticals - MAH‑led market entry and lifecycle management"/>
              </div>
              <p class="font-bold leading-tight mb-3">
                <span class="block">MAH‑led market entry and</span>
                <span class="block">lifecycle management</span>
              </p>
              <p>
                Support for regulatory approval for marketing authorisations and ongoing maintenance, combined with integrated commercial supply and distribution across hospital and pharmacy settings.
              </p>
            </div>

            <div class="glide__slide bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 px-5 pb-16 mr-6 my-2">
              <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
                <img src="{{ asset('image/End-to-end.svg') }}" alt="Smartway Pharmaceuticals - Transition from early access to licensed supply" title="Smartway Pharmaceuticals - Transition from early access to licensed supply"/>
              </div>
              <p class="font-bold leading-tight mb-10">
                <span class="block">Transition from early</span>
                <span class="block">access to licensed supply</span>
              </p>
              <p>
                Planning and execution of the pathway from unlicensed or early access supply into routine, licensed commercial distribution, supporting continuity of access.
              </p>
            </div>

            <div class="glide__slide bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 pb-16 px-4 my-2">
              <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
                <img src="{{ asset('image/regional-partnerships.png') }}" alt="Smartway Pharmaceuticals - Regional or portfolio expansion partnerships" title="Smartway Pharmaceuticals - Regional or portfolio expansion partnerships"/>
              </div>
              <p class="font-bold leading-tight mb-10">
                <span class="block">Regional or portfolio</span>
                <span class="block">expansion partnerships</span>
              </p>
              <p>
                Selective territory commercialisation for established products, providing regulatory and commercial infrastructure without the need for in‑country build‑out.
              </p>
            </div>

            <div class="glide__slide bg-alabaster rounded-10px card-box-shadow text-center pt-10 lg:pb-20 pb-16 px-8 mr-6 my-2">
              <div class="circle-box-shadow w-50 h-50 rounded-full mx-auto mb-5 bg-lochmara flex justify-center items-center">
                <img src="{{ asset('image/strategic-discussion.png') }}" alt="Smartway Pharmaceuticals - Initiate a strategic discussion" title="Smartway Pharmaceuticals - Initiate a strategic discussion"/>
              </div>
              <p class="font-bold leading-tight mb-10">
                Initiate a strategic discussion
              </p>
              <p>
                Market access and product commercialisation is a core strategic function within Smartway. We engage selectively with partners seeking structured, long-term entry into the UK and regulated international markets.
              </p>
            </div>
          </div>

          <div class="glide__bullets" data-glide-el="controls[nav]">
            <button class="glide__bullet" data-glide-dir="=0"></button>
            <button class="glide__bullet" data-glide-dir="=1"></button>
            <button class="glide__bullet" data-glide-dir="=2"></button>
            <button class="glide__bullet" data-glide-dir="=3"></button>
            <button class="glide__bullet" data-glide-dir="=4"></button>
          </div>
        </div>
      </div>
    </div>

    <div class="4xl:text-2xl sm:text-xl text-lg 4xl:leading-37px leading-24px mt-16">
        <p>
          To discuss a potential licensing or commercialisation opportunity, 
          please <a href="{{ route('connect-with-us') }}" class="text-25px font-semibold underline -tracking-0.5px text-lochmara">Contact Us</a> to arrange a confidential conversation.
        </p>
    </div>
  </section>
@endsection

@push('scripts')
  <script src="{{ mix('js/why-partner-slider.js') }}" defer></script>
@endpush